Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
9,10-dimethyl-1,2-benzanthracene | [no description available] | medium | 26 | 0 | ortho-fused polycyclic arene; tetraphenes | carcinogenic agent |
phosphorus radioisotopes | [no description available] | medium | 1 | 0 | | |
7-(hydroxymethyl)-12-methylbenz(a)anthracene sulfate ester | [no description available] | medium | 6 | 0 | | |
proadifen | [no description available] | medium | 1 | 0 | diarylmethane | |
3-methylcholanthrene | [no description available] | medium | 2 | 0 | ortho- and peri-fused polycyclic arene | aryl hydrocarbon receptor agonist; carcinogenic agent |
carbon disulfide | [no description available] | medium | 1 | 0 | one-carbon compound; organosulfur compound | |
phenobarbital | [no description available] | medium | 2 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
metyrapone | [no description available] | medium | 1 | 0 | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
beta-naphthoflavone | [no description available] | medium | 1 | 0 | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist |
alpha-naphthoflavone | [no description available] | medium | 1 | 0 | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist; aryl hydrocarbon receptor antagonist; EC 1.14.14.14 (aromatase) inhibitor |
7-hydroxymethylbenz(a)anthracene | [no description available] | medium | 2 | 0 | | |
beta carotene | [no description available] | medium | 1 | 0 | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A |
dehydroepiandrosterone | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid | androgen; human metabolite; mouse metabolite |
pentachlorophenol | [no description available] | medium | 1 | 0 | aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes | human xenobiotic metabolite |
chlorine | [no description available] | medium | 1 | 0 | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite |
5-hydroxymethylchrysene | [no description available] | medium | 1 | 0 | | |
benzo(a)pyrene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mouse metabolite |
masoprocol | [no description available] | medium | 1 | 0 | nordihydroguaiaretic acid | antineoplastic agent; hypoglycemic agent; lipoxygenase inhibitor; metabolite |
bradykinin | [no description available] | medium | 1 | 0 | oligopeptide | human blood serum metabolite; vasodilator agent |
arachidonic acid | [no description available] | medium | 1 | 0 | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
5,8,11,14-eicosatetraynoic acid | [no description available] | medium | 1 | 0 | long-chain fatty acid | |
digitonin | [no description available] | medium | 1 | 0 | | |
carmustine | [no description available] | medium | 1 | 0 | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent |
glutathione disulfide | [no description available] | medium | 1 | 0 | glutathione derivative; organic disulfide | Escherichia coli metabolite; mouse metabolite |
phenyl acetate | [no description available] | medium | 1 | 0 | benzenes; phenyl acetates | |
ethyl acetate | [no description available] | medium | 1 | 0 | acetate ester; ethyl ester; volatile organic compound | EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; metabolite; polar aprotic solvent; Saccharomyces cerevisiae metabolite |
phenanthrene | [no description available] | low | 0 | 0 | ortho-fused polycyclic arene; ortho-fused tricyclic hydrocarbon; phenanthrenes | environmental contaminant; mouse metabolite |
benzanthrone | [no description available] | low | 0 | 0 | phenanthrenes | |
9,10-phenanthrenequinone | [no description available] | low | 0 | 0 | phenanthrenes | |
dibenzo(aj)anthracene | [no description available] | low | 0 | 0 | phenanthrenes | |
1-methylphenanthrene | [no description available] | low | 0 | 0 | phenanthrenes | mutagen |
dibenzo(a,e)fluoranthene | [no description available] | low | 0 | 0 | phenanthrenes | |
7-nitrobenzanthracene | [no description available] | low | 0 | 0 | phenanthrenes | |
halofantrine | [no description available] | low | 0 | 0 | phenanthrenes | |
3-nitroperylene | [no description available] | low | 0 | 0 | phenanthrenes | |
1-(2-phenanthrenyl)ethanone | [no description available] | low | 0 | 0 | phenanthrenes | |
benz(j)aceanthrylene | [no description available] | low | 0 | 0 | phenanthrenes | |
benz(l)aceanthrylene | [no description available] | low | 0 | 0 | phenanthrenes | |
norbuprenorphine | [no description available] | low | 0 | 0 | phenanthrenes | |
chrysene-1,4-dione | [no description available] | low | 0 | 0 | phenanthrenes | |
Hircinol | [no description available] | low | 0 | 0 | phenanthrenes | |
nitrobenzanthrone | [no description available] | low | 0 | 0 | phenanthrenes | |
7-benzylidenenaltrexone | [no description available] | low | 0 | 0 | phenanthrenes | |
methylnaltrexone | [no description available] | low | 0 | 0 | phenanthrenes | |
6 beta-hydroxynaltrexone | [no description available] | low | 0 | 0 | phenanthrenes | |
noroxycodone | [no description available] | low | 0 | 0 | phenanthrenes | |
noroxymorphone | [no description available] | low | 0 | 0 | phenanthrenes | |
(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | [no description available] | low | 0 | 0 | phenanthrenes | |
trk 820 | [no description available] | low | 0 | 0 | phenanthrenes | |
osu 03012 | [no description available] | low | 0 | 0 | antibiotic antifungal drug; aromatic amide; glycine derivative; organofluorine compound; phenanthrenes; pyrazoles | antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |